Primary (AL) amyloidosis is the most prevalent type of systemic amyloidosis, and management of this disease has evolved through the years from supportive care to aggressive treatments that include ...

Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...

Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.

Amyloidosis occurs when the body produces abnormal proteins that bind together to form a substance called amyloid. Amyloids can deposit in any tissue or organ, including the heart, kidneys, liver and ...

The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has added ...

The association between amyloidosis and aortic valve stenosis has attracted considerable international attention. However, when researchers at Umeå University investigated the hereditary form of ...

"These forms of cardiac amyloidosis are rare but increasingly recognized. For the first time, patients with both forms of amyloidosis have undergone deep phenotyping using cardiac biomarkers, 12-lead ...

DEAR DR. ROACH: I recently saw a friend who had been diagnosed with ALECT2 amyloidosis, a form of chronic kidney disease that is not well-understood but is considered fatal. Her illness was first ...

The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other ...